Skip to main content

UBS Group AG

Position in BGLC — BioNexus Gene Lab Corp

CIK 1610520 ZURICH, V8

Position in BGLC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$196
-$298 QoQ
Shares Held
101
-56.3% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#2
of 3 holders
Holding Since
Mar 2024
8 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BGLC Over Time

Shares Held

Position Value (USD)

Position in Specialty Chemicals

Basic Materials · as of Jun 30, 2026

UBS Group AG holds $4,668,709,836 across 61 Specialty Chemicals names. BGLC ranks #61 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open

All Filings in BGLC

Export CSV
8 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $196 101
2026-03-31 $494 231
2025-09-30 $41,714 7,626
2025-06-30 $29,354 9,562
2025-03-31 $1 4
2024-12-31 $30,696 109,632
2024-09-30 $37,072 83,308
2024-03-31 $5,943 8,418